statistiche ricercatore

Continente	#
NA - Nord America	694
EU - Europa	353
AS - Asia	346
SA - Sud America	55
Continente sconosciuto - Info sul continente non disponibili	38
AF - Africa	21
OC - Oceania	1
Totale	1.508

Nazione	#
US - Stati Uniti d'America	670
IT - Italia	157
SG - Singapore	102
VN - Vietnam	72
CN - Cina	61
RU - Federazione Russa	49
BR - Brasile	45
HK - Hong Kong	35
DE - Germania	27
FR - Francia	20
IE - Irlanda	19
BD - Bangladesh	18
GB - Regno Unito	17
NL - Olanda	16
IN - India	15
CI - Costa d'Avorio	12
SE - Svezia	12
CA - Canada	9
MX - Messico	7
PL - Polonia	7
FI - Finlandia	6
JP - Giappone	6
AT - Austria	5
ES - Italia	5
PK - Pakistan	5
IQ - Iraq	4
TR - Turchia	4
UA - Ucraina	4
ZA - Sudafrica	4
EC - Ecuador	3
MY - Malesia	3
NP - Nepal	3
PS - Palestinian Territory	3
AR - Argentina	2
CL - Cile	2
CR - Costa Rica	2
CZ - Repubblica Ceca	2
HN - Honduras	2
TH - Thailandia	2
AU - Australia	1
BE - Belgio	1
BY - Bielorussia	1
CO - Colombia	1
DZ - Algeria	1
GA - Gabon	1
GE - Georgia	1
GP - Guadalupe	1
HR - Croazia	1
HU - Ungheria	1
ID - Indonesia	1
IL - Israele	1
JM - Giamaica	1
KE - Kenya	1
KR - Corea	1
KW - Kuwait	1
KZ - Kazakistan	1
LA - Repubblica Popolare Democratica del Laos	1
LB - Libano	1
LT - Lituania	1
MA - Marocco	1
MD - Moldavia	1
MT - Malta	1
PE - Perù	1
PH - Filippine	1
PR - Porto Rico	1
PY - Paraguay	1
SA - Arabia Saudita	1
SV - El Salvador	1
SY - Repubblica araba siriana	1
TN - Tunisia	1
TW - Taiwan	1
UZ - Uzbekistan	1
Totale	1.470

Nome	#
Bloodstream infections in the COVID-19 era: results from an Italian multi-centre study	205
Ceftazidime-Avibactam for the Treatment of Multidrug-Resistant Pathogens: A Retrospective, Single Center Study	181
Use of dalbavancin in skin, bone and joint infections: A real-life experience in an Italian center	168
Antifungal Combinations against Candida Species: From Bench to Bedside	142
Candidemia in Internal Medicine: Facing the New Challenge	139
The sources of antimicrobial peptides against Gram-positives and Gramnegatives: our research experience	118
The Clinical Characteristics of Bloodstream Infections Due to Candida spp. in Patients Hospitalized in Intensive Care Units during the SARS-CoV-2 Pandemic: The Results of a Multicenter Study	118
Clinical and molecular characteristics of KPC-producing Klebsiella pneumoniae bloodstream infections: Results of a multicentre study	117
In Vitro Activity of Novel Lipopeptides against Triazole-Resistant Aspergillus fumigatus	107
In vitro activities of lipopeptides against fluconazole-resistant Candida auris	83
Multicenter study of invasive pulmonary aspergillosis in intensive care units: facing the new challenge	75
Ceftazidime–Avibactam in Critically Ill Patients: A Multicenter Observational Study	55
Totale	1.508

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	42	0	0	0	0	0	0	6	0	12	2	8	14
2022/2023	133	8	11	6	7	11	35	3	11	18	1	16	6
2023/2024	79	9	3	17	9	17	13	2	1	4	2	1	1
2024/2025	202	25	15	11	5	8	13	21	16	25	10	26	27
2025/2026	896	51	38	44	82	73	50	173	71	84	95	89	46
2026/2027	156	66	24	32	34	0	0	0	0	0	0	0	0
Totale													1.508